Bronchodilator Responsiveness Measured by Spirometry and Impulse Oscillometry in Patients with Asthma After Short Acting Antimuscarinic and/or Beta-2-Agonists Inhalation

References

• Asthma. GIf. Global Strategy for Asthma Management and Prevention, 2022; 2022. https://ginasthma.org/gina-reports/. Accessed December 4, 2024.
   Google Scholar
• Graham BL, Steenbruggen I, Miller MR, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70–e88. doi:10.1164/rccm.201908-1590ST
   PubMed Web of Science ®Google Scholar
• Janson C, Malinovschi A, Amaral AFS, et al. Bronchodilator reversibility in asthma and COPD: findings from three large population studies. Eur Respir J. 2019;54(3):1900561. doi:10.1183/13993003.00561-2019
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Sartori G, Patruno V, Fantin A. Bronchodilator reversibility in patients with asthma and persistent airflow limitation. Lancet Respir Med. 2022;10(11):e94–e95. doi:10.1016/S2213-2600(22)00363-0
   PubMedGoogle Scholar
• Mauer Y, Taliercio RM. Managing adult asthma: the 2019 GINA guidelines. Cleve Clin J Med. 2020;87(9):569–575. doi:10.3949/ccjm.87a.19136
   PubMed Web of Science ®Google Scholar
• Davis BE, Cockcroft DW. Effect of daily dosing with tiotropium against methacholine induced bronchoconstriction in asthmatics. Pulm Pharmacol Ther. 2022;77:102174. doi:10.1016/j.pupt.2022.102174
   PubMed Web of Science ®Google Scholar
• Matera MG, Cazzola M. Muscarinic Receptor Antagonists. Handb Exp Pharmacol. 2017;237:41–62. doi:10.1007/164_2016_68
   PubMedGoogle Scholar
• Kirkland SW, Vandenberghe C, Voaklander B, Nikel T, Campbell S, Rowe BH. Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma. Cochrane Database Syst Rev. 2017;1(1):Cd001284. doi:10.1002/14651858.CD001284.pub2
   PubMedGoogle Scholar
• Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391(10122):783–800. doi:10.1016/S0140-6736(17)33311-1
   PubMed Web of Science ®Google Scholar
• Teoh L, Cates CJ, Hurwitz M, Acworth JP, van Asperen P, Chang AB. Anticholinergic therapy for acute asthma in children. Cochrane Database Syst Rev. 2012;(4):CD003797. doi:10.1002/14651858.CD003797.pub2
   PubMed Web of Science ®Google Scholar
• Cazzola M, Calzetta L, Matera MG. Long-acting muscarinic antagonists and small airways in asthma: which link? Allergy. 2021;76(7):1990–2001. doi:10.1111/all.14766
   PubMed Web of Science ®Google Scholar
• Kew KM, Dahri K. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma. Cochrane Database Syst Rev. 2016;2016(1):CD011721. doi:10.1002/14651858.CD011721.pub2
   PubMedGoogle Scholar
• Jarenbäck L, Eriksson G, Peterson S, Ankerst J, Bjermer L, Tufvesson E. Bronchodilator response of advanced lung function parameters depending on COPD severity. Int J Chron Obstruct Pulmon Dis. 2016;11:2939–2950. doi:10.2147/copd.S111573
   PubMed Web of Science ®Google Scholar
• van den Bosch WB, James AL, Tiddens H. Structure and function of small airways in asthma patients revisited. Eur Respir Rev. 2021;30(159):200186. doi:10.1183/16000617.0186-2020
   PubMed Web of Science ®Google Scholar
• Postma DS, Brightling C, Baldi S, et al. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study. Lancet Respir Med. 2019;7(5):402–416. doi:10.1016/S2213-2600(19)30049-9
   PubMed Web of Science ®Google Scholar
• Almeshari MA, Alobaidi NY, Sapey E, Usmani O, Stockley RA, Stockley JA. Small Airways Response to Bronchodilators in Adults with Asthma or COPD: a Systematic Review. Int J Chron Obstruct Pulmon Dis. 2021;16:3065–3082. doi:10.2147/COPD.S331995
   PubMed Web of Science ®Google Scholar
• McFadden ER, Linden DA. A reduction in maximum mid-expiratory flow rate. A spirographic manifestation of small airway disease. Am J Med. 1972;52(6):725–737. doi:10.1016/0002-9343(72)90078-2
   PubMed Web of Science ®Google Scholar
• Kwon DS, Choi YJ, Kim TH, et al. FEF(25-75%) Values in Patients with Normal Lung Function Can Predict the Development of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2020;15:2913–2921. doi:10.2147/COPD.S261732
   PubMed Web of Science ®Google Scholar
• Garg V, Parakh A. Spirometry vs Impulse oscillometry in evaluation of children with asthma. Eur Respir J. 2020;56(suppl 64):2647. doi:10.1183/13993003.congress-2020.2647
   Google Scholar
• Xu J, Sun X, Zhu H, et al. Long-term variability of impulse oscillometry and spirometry in stable COPD and asthma. Respir Res. 2022;23(1):262. doi:10.1186/s12931-022-02185-5
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Kaminsky DA. What does airway resistance tell us about lung function? Respir Care. 2012;57(1):85–96. doi:10.4187/respcare.01411
   PubMed Web of Science ®Google Scholar
• Bates JHT, Irvin CG, Farré R, Hantos Z. Oscillation Mechanics of the Respiratory System. Compr Physiol. 2017;548.
   Google Scholar
• Goldman MD, Saadeh C, Ross D. Clinical applications of forced oscillation to assess peripheral airway function. Respir Physiol Neurobiol. 2005;148(1–2):179–194. doi:10.1016/j.resp.2005.05.026
   PubMed Web of Science ®Google Scholar
• Oostveen E, Boda K, van der Grinten CP, et al. Respiratory impedance in healthy subjects: baseline values and bronchodilator response. Eur Respir J. 2013;42(6):1513–1523. doi:10.1183/09031936.00126212
   PubMed Web of Science ®Google Scholar
• Bossé Y. Understanding the fundamentals of oscillometry from a strip of lung tissue. Front Physiol. 2022;13. doi:10.3389/fphys.2022.978332
   Web of Science ®Google Scholar
• Oostveen E, MacLeod D, Lorino H, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003;22(6):1026–1041. doi:10.1183/09031936.03.00089403
   PubMed Web of Science ®Google Scholar
• Jarenbäck L, Ankerst J, Bjermer L, Tufvesson E. Acinar ventilation heterogeneity in COPD relates to diffusion capacity, resistance and reactance. Respir Med. 2016;110:28–33. doi:10.1016/j.rmed.2015.11.005
   PubMed Web of Science ®Google Scholar
• Gelb AF, Karpel J, Wise RA, Cassino C, Johnson P, Conoscenti CS. Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate-to-severe persistent asthma. Pulm Pharmacol Ther. 2008;21(4):630–636. doi:10.1016/j.pupt.2008.02.005
   PubMed Web of Science ®Google Scholar
• Watson WT, Becker AB, Simons FE. Comparison of ipratropium solution, fenoterol solution, and their combination administered by nebulizer and face mask to children with acute asthma. J Allergy Clin Immunol. 1988;82(6):1012–1018. doi:10.1016/0091-6749(88)90138-8
   PubMed Web of Science ®Google Scholar
• Westby M, Benson M, Gibson P. Anticholinergic agents for chronic asthma in adults. Cochrane Database Syst Rev. 2004;2004(3):CD003269. doi:10.1002/14651858.CD003269.pub2
   PubMedGoogle Scholar
• Salo D, Tuel M, Lavery RF, Reischel U, Lebowitz J, Moore T. A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma. J Emerg Med. 2006;31(4):371–376. doi:10.1016/j.jemermed.2006.05.025
   PubMed Web of Science ®Google Scholar
• Graff S, Bricmont N, Moermans C, et al. Clinical and biological factors associated with irreversible airway obstruction in adult asthma. Respir Med. 2020;175:106202. doi:10.1016/j.rmed.2020.106202
   PubMed Web of Science ®Google Scholar
• Rau JL. The inhalation of drugs: advantages and problems. Respir Care. 2005;50(3):367–382.
   PubMedGoogle Scholar
• Cockcroft DW, Berscheid BA. Volume Adjustment of Maximal Midexpiratory Flow: importance of Changes in Total Lung Capacity. Chest. 1980;78(4):595–600. doi:10.1378/chest.78.4.595
   PubMed Web of Science ®Google Scholar